Germline cancer-predisposition variants (CPVs) can be helpful in predicting risk in some pediatric cancers. However, CPV risk association in children with rhabdomyosarcoma has not been well studied. A new report led by researchers ...
Mar 28, 2024
0
0
A simple blood test could help guide the treatment of children with the cancer rhabdomyosarcoma, a new study reports.
Oct 21, 2022
0
20
A phase 2 clinical trial has found that combining a molecular targeted drug called temsirolimus with chemotherapy shows promise in the treatment of rhabdomyosarcoma, the most common soft tissue sarcoma in childhood. The Children's ...
Sep 13, 2019
0
7
Small spots on CT scans of the lungs of children with muscle cancer do not have an adverse effect on survival, according to an international research team in the Journal for Clinical Oncology. This conclusion has direct consequences ...
Feb 15, 2019
0
9
St. Jude Children's Research Hospital investigators have completed the most comprehensive analysis yet of a common pediatric solid tumor, identifying weaknesses to target and a promising precision medicine that is now in ...
Aug 23, 2018
0
8
(HealthDay)—Children suffering from rhabdomyosarcoma, a rare cancer of the muscle tissue, may have better chances for a cure if they have extended chemotherapy, a new study finds.
Jun 4, 2018
0
2
A dual-pronged strategy using two experimental cancer drugs together could successfully treat a childhood cancer by inhibiting tumour growth and blocking off the escape routes it uses to become resistant to treatment, finds ...
Nov 1, 2013
0
0
The precise targeting and limited dosing of radiation via proton therapy is proving to be an advantage in ongoing efforts to reduce treatment side effects among head and neck cancer patients, according to a new study of pediatric ...
Sep 24, 2013
0
0
A Cancer Research UK funded trial will offer new treatments for children and adults with a form of muscle cancer called rhabdomyosarcoma that has returned or does not respond to current treatments.
Oct 22, 2012
0
0
Rhabdomyosarcoma is the most common childhood cancer in the soft tissues, and it mainly originates in the muscles. It represents almost 5% of pediatric tumors, and the survival rate is between 60% and 70%. The work published ...
Jan 29, 2020
0
3
